Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2000-06-14
2002-10-15
Myers, Carla J. (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C435S006120, C435S091100, C435S091200
Reexamination Certificate
active
06465171
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the detection of the presence of reverse transcriptase enzymatic activity in eukaryotic cell lines. Specifically, the present invention relates to a method for the discrimination of endogenous reverse transcriptase activity in avian cell lines used as substrates for the manufacture of biological products including viral vaccines from exogenous infectious retrovirus.
2. Summary of the Related Art
Of the commonly used viral vaccines licensed in the US, measles, mumps, yellow fever and influenza are produced in chicken cells derived from embryonated eggs (Plotkin and Mortimer (1994) Vaccines 2
nd
Edition, Philadelphia, Pa., Saunders). Furthermore, cell substrates can be used for production of a variety of biological products, such as vaccines for hepatitis A, polio, and rabies as well as proteins, glycoproteins, and lipoproteins. The use of living cell substrates for the production of live attenuated virus provides the opportunity for infection of these cell lines by adventitious retroviruses. These live attenuated vaccines may act as vehicles for the transmission of different kinds of microorganisms or other undesired agents. The risk for inadvertent transmission is particularly high for live attenuated virus vaccine since they cannot be subjected to an inactivation procedure and most of them are injected into human, thus by-passing non-specific immune protection mechanisms. Thus, to ensure safety of vaccines for human use the cell substrates for vaccine production have been tested for the presence of replication-competent retroviruses that could be passed to human hosts during immunization (WHO Technical Report Series, 1994). Vaccines produced in continuous cell lines of any origin are required by experts in the field to be free of RT activity (Boni et al., (1996) Clin. & Diag. Virol. 5: 43-53.)
Avian cell lines are frequently used in the production of vaccines. Avian retroviruses classified within the ALSV subgroup E have been shown to be maintained in the germ line as endogenous virus (ev) loci and passed to progeny in a Mendelian fashion [16]. Chickens bred to be resistant to the ALSV subgroup E endogenous viruses (e.g., line-0 chickens), and therefore lacking ALV (ev) loci, have been shown to carry other germ line sequences, some of which are believed to be remnants of ancient proviral genomes. Another family of endogenous avian retroviruses of interest is referred to as (EAV-0) since they were first isolated from the (ev
−
) genome of line-0 chickens [17-20]. The EAV-0 loci have been shown to be highly expressed in embryonic cells derived from the avian genus, Gallus [21]. Moreover, these particles have been shown to contain RNA genomes with active RT-primer tRNA. Recent studies have shown that the particles from the EAV-0 endogenous retrovirus family are most likely responsible for a large portion of the particle-associated RT activity found in supernatants of cultured chick embryo fibroblasts [21]. Sequence analysis of several different EAV-0 isolates have indicated that a large deletion has occurred in the env gene which provides the scientific basis for and supports direct evidence for the replication incompetence of the particle-associated RT activity in cell culture [21].
Testing for the presence of retrovirus in cell substrates has been accomplished by assaying for the presence of reverse transcriptase (RT) activity based on the RNA-dependent synthesis of DNA (U.S. Pat. No. 3,755,086; Poiesz et al., (1980) Proc. Natl. Acad. Sci. USA, 77: 1415; Hoffman et al., (1985) Virology 147: 326). The RT enzyme or RNA-dependent DNA polymerase is essential for the establishment of the proviral state after infection of a cell and therefore is a mandatory component of the virus particle. Unfortunately, regardless of the templates and primers used, these RT assays are relatively insensitive compared to other more time-consuming assays for the detection of retroviruses such as cell culture or antigen detection methods. Attempts to detect uncharacterized retroviruses by the use of the polymerase chain reaction (PCR) with primers from conserved genomic regions have met with some success, but they lack the ability to assay for more than one infectious virus at a time, that is, the PCR test is not an open test. Furthermore, PCR will not detect the presence of unknown virus or viruses that have mutated in the region of the genome used for PCR amplification. PCR methods that utilize primers to specific retroviruses may not detect mutant variations of that virus if the mutation occurs in area to which the primers hybridize. Furthermore, PCR methods that utilize primers to specific retroviruses may require multiple and time consuming iterations to detect all possible retroviral species that may infect the substrate cell. Thus, both traditional RT assay and PCR based detection of retrovirus based on amplification of specific sequences are both relatively insensitive and can be time-consuming and difficult.
Recently, highly sensitive PCR based assays have been developed that can detect RNA-dependent DNA polymerase in the equivalent of one to ten particles (Silver et al. (1993) Nucleic Acids Res. 21: 3593-4; U.S. Pat. No. 5,807,669). One such assay, designated as PBRT (PCR-based reverse transcriptase), has been used to detect RT activity in a variety of samples (Pyra et al. (1994) Proc. Natl. Acad. Sci. USA 51: 1544-8; Boni, et al. (1996) J. Med. Virol. 49: 23-28). This assay is 10
6
-10
7
more sensitive than the conventional RT assay. In one instance PBRT was used to detect RT activity in live attenuated viral vaccines grown in chicken cells (Boni et al. (1996) Clin. Diag. Virol. 5: 43-53). The presence of RT activity in avian substrate cells where none had previously been detected is a potential source of concern since this activity may indicate the presence of a retrovirus that can potentially replicate in human cells. Thus, administration of a licensed viral vaccine may be the conduit for the inadvertent administration an adventitious retrovirus that can infect human cells and persist long-term as an integral part of the host genome. This is accomplished through the retroviral replication cycle that is characteristic of all retroviruses and depends in part upon the enzymatic activity of RT (Varmus and Swanstrom (1984) RNA Tumor Viruses, Molecular Biology of Tumor Viruses vol 2, 2
nd
Edition, New York, Cold Spring Harbor Laboratory pp. 75-134; Baltimore (1970) Nature 226: 1209-11). Since retroviruses can be pathogenic in susceptible species, vaccines and other biological products for human use should be free of infectious retroviruses.
Alternatively, the presence of RT activity associated with cell substrates used in the production of viral vaccines may be due to low levels of RT-like activity associated with polymerases endogenous to the cell substrates. Moreover, it has recently been discovered that at least some of the RT activity associated with chicken cells used as substrates in the manufacture of live attenuated viral vaccines is associated with a particle that contains RNAs related to the EAV-0 family of retroviruses (Weissmahr et al. (1997) J. Virol. 71: 3005-12). Sequences of the EAV-0 family are prevalent in the genus Gallus and have been described as ancient proviral genomes (Dunwiddie et al. (1986) J. Virol. 59: 669-75); Resnick et al. (1990) J. Virol. 64: 4640-53; Boyce-Jacino et al. (1992) J. Virol. 66: 4919-29). Early studies using traditional RT assays had reported a particle-associated RT activity in the allantoic fluid of embryonated chicken eggs from retrovirus-free chickens and in concentrated medium of primary and secondary chicken embryo fibroblast cultures (Bauer & Hoffschneider (1977) Proc. Natl. Acad. Sci. USA 73: 3025-9; Bauer et al (1977) Eur. J. Biochem. 79: 345-54; Bauer et al. (1978) Biochim. Biophys. Acta 518: 125-37). No infectious retrovirus was found associated with the RT activity using avian target cells (Baue
Goebel Scott
Harmon Maurice
Lapps William
Pelloquin Francois
Tartaglia Jim
Aventis Pasteur
McDonnell & Boehnen Hulbert & Berghoff
Myers Carla J.
Spiegler Alexander H.
LandOfFree
CoRT-PCR assay for the discrimination of endogenous reverse... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CoRT-PCR assay for the discrimination of endogenous reverse..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CoRT-PCR assay for the discrimination of endogenous reverse... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2981679